Skip to main content

CASE REPORT article

Front. Med.
Sec. Hematology
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1373397

Case report: POEMS syndrome with portal hypertension

Provisionally accepted
Xiaotong Xu Xiaotong Xu 1Changyou Jing Changyou Jing 2Tong Zhu Tong Zhu 2Minjie Jiang Minjie Jiang 3Yunlai Fu Yunlai Fu 3Jianjun Li Jianjun Li 2*Qinghua Meng Qinghua Meng 4*
  • 1 Department of Liver Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China
  • 2 Liver Disease and Cancer Interventional Therapy Center, Beijing Youan Hospital, Capital Medical University, Beijing, China
  • 3 oncology department, Department of Liver Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China
  • 4 Beijing Youan Hospital, Capital Medical University, Beijing, China

The final, formatted version of the article will be published soon.

    This patient was an elderly patient with abdominal distension and shortness of breath.According to relevant examinations, his condition was initially considered to be related to cirrhosis, but pathological biopsy confirmed the diagnosis of noncirrhotic portal hypertension of unknown aetiology. The portal vein pressure was significantly reduced after transjugular intrahepatic portosystemic shunt (TIPS). Nevertheless, the relief of the hydrothorax and ascites was not significant, and the numbness in both lower limbs gradually worsened. POEMS syndrome was ultimately diagnosed following a comprehensive examination. After two courses of bortezomib combined with dexamethasone, the patient died due to a systemic infection. The clinical symptoms of the patient were atypical, as was the presence of portal hypertension, which hindered the diagnosis of POEMS. Due to the patient's advanced age, the diagnosis was delayed, and the prognosis was poor. This case reminds clinicians that POEMS patients can also have portal hypertension as the main manifestation.

    Keywords: :POEMS syndrome, portal hypertension, case report, Ascites, Hydrothorax

    Received: 10 Mar 2024; Accepted: 02 Jul 2024.

    Copyright: © 2024 Xu, Jing, Zhu, Jiang, Fu, Li and Meng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Jianjun Li, Liver Disease and Cancer Interventional Therapy Center, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China
    Qinghua Meng, Beijing Youan Hospital, Capital Medical University, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.